<?xml version="1.0" encoding="UTF-8"?>
<ref id="r73">
 <label>73</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Bak</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Tischer</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Dragon</surname>
   <given-names>A</given-names>
  </string-name>, 
  <string-name>
   <surname>Ravens</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Pape</surname>
   <given-names>L</given-names>
  </string-name>, 
  <string-name>
   <surname>Koenecke</surname>
   <given-names>C</given-names>
  </string-name>, 
  <string-name>
   <surname>Oelke</surname>
   <given-names>M</given-names>
  </string-name>, 
  <string-name>
   <surname>Blasczyk</surname>
   <given-names>R</given-names>
  </string-name>, 
  <string-name>
   <surname>Maecker-Kolhoff</surname>
   <given-names>B</given-names>
  </string-name>, 
  <string-name>
   <surname>Eiz-Vesper</surname>
   <given-names>B</given-names>
  </string-name>. 
  <article-title>Selective Effects of mTOR Inhibitor Sirolimus on Na√Øve and CMV-Specific T Cells Extending Its Applicable Range Beyond Immunosuppression.</article-title>
  <source>Front Immunol</source>. 
  <year>2018</year>; 
  <volume>9</volume>:
  <fpage>2953</fpage>. 
  <pub-id pub-id-type="doi">10.3389/fimmu.2018.02953</pub-id>
  <?supplied-pmid 30619313?>
  <pub-id pub-id-type="pmid">30619313</pub-id>
 </mixed-citation>
</ref>
